跳至主要内容
临床试验/ACTRN12613000269730
ACTRN12613000269730招募中4 期

Pancreatic Enzyme Replacement Therapy in patients after Major Upper Gastro-Intestinal Operations (PERTUGI) - A Randomized Controlled Trial to Assess Weight Change, Quality of Life, and Faecal Elastase in patients receiving enzyme supplementation with Creon (Trademark)

Box Hill Hospital Department of Surgery0 个研究点目标入组 24 人开始时间: 2013年3月6日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • post major upper gastrointestinal surgery at least 3months, are more than 6 weeks post chemoradiotherapy and are clinically stable. Can provide informed consent to complete the study . It is an expectation that patients included will be able to attend one initial and two follow-up appointments.

排除标准

  • Participants who:
  • - cannot cease alcohol consumption
  • - whom informed consent cannot be obtained
  • -those patients with chronic pancreatitis, celiac disease, Chron’s disease and Zollinger-Ellison syndrome
  • -Any patient who is known to be hypersensitive to porcine protein must also be excluded, as this constitutes the primary active ingredient of the trial medication

研究者

发起方
Box Hill Hospital Department of Surgery

相似试验